Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Acadia Pharmaceuticals (ACAD) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.89% |
| Dec 31, 2025 | 15.58% |
| Sep 30, 2025 | 19.56% |
| Jun 30, 2025 | 15.83% |
| Mar 31, 2025 | 14.95% |
| Dec 31, 2024 | 27.06% |
| Sep 30, 2024 | 24.91% |
| Jun 30, 2024 | 22.05% |
| Mar 31, 2024 | 15.31% |
| Dec 31, 2023 | -51.24% |
| Sep 30, 2023 | 47.39% |
| Jun 30, 2023 | 14.89% |
| Mar 31, 2023 | 57.61% |
| Dec 31, 2022 | -23.02% |
| Sep 30, 2022 | 39.87% |
| Jun 30, 2022 | 38.93% |
| Mar 31, 2022 | 31.70% |
| Dec 31, 2021 | 52.46% |
| Sep 30, 2021 | 66.91% |
| Jun 30, 2021 | 42.75% |